{"resourceType": "ResearchStudy", "contained": [{"resourceType": "EvidenceVariable", "id": "NCT00806442-drug------borage-seed-oil-and-echium-seed-oil", "name": "NCT00806442_drug______borage_seed_oil_and_echium_seed_oil", "title": "Borage Seed Oil and Echium Seed Oil", "status": "active", "description": "2 g/day of borage seed oil and 7 g/day of echium seed oil to provide 1.6 g/day of GLA and 0.9 g/day of SDA.", "note": [{"text": "suggested alternative name: CROSSENTIAL GLA TG40"}, {"text": "suggested alternative name: INCROMEGA V3"}], "useContext": [{"code": {"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-InterventionType", "code": "interventionType", "display": "Intervention Type for ClinicalTrials.gov"}, "valueCodeableConcept": {"text": "DRUG"}}]}, {"resourceType": "EvidenceVariable", "id": "NCT00806442-dietary-supplement------corn-oil", "name": "NCT00806442_dietary_supplement______corn_oil", "title": "Corn Oil", "status": "active", "description": "9 g/day of corn oil", "useContext": [{"code": {"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-InterventionType", "code": "interventionType", "display": "Intervention Type for ClinicalTrials.gov"}, "valueCodeableConcept": {"text": "DIETARY_SUPPLEMENT"}}]}, {"resourceType": "Group", "id": "NCT00806442-comparison-group-0", "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: [System]-to-FEvIR Converter"}}], "identifier": [{"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-comparison-group-0", "assigner": {"display": "Computable Publishing LLC"}}], "title": "NCT00806442 Comparison Group: 1: Borage Seed Oil and Echium Seed Oil", "status": "active", "description": "Borage/Echium plant seed oils: 2 g/day of borage seed oil and 7 g/day of echium seed oil to provide 1.6 g/day of GLA and 0.9 g/day of SDA.", "useContext": [{"code": {"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure", "code": "ArmGroupType", "display": "Arm Group Type"}, "valueCodeableConcept": {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ArmGroupType", "code": "EXPERIMENTAL", "display": "Experimental"}]}}], "membership": "conceptual", "characteristic": [{"code": {"text": "Exposed to"}, "valueReference": {"reference": "#NCT00806442-drug------borage-seed-oil-and-echium-seed-oil", "type": "EvidenceVariable", "display": "Drug: Borage Seed Oil and Echium Seed Oil"}, "exclude": false}]}, {"resourceType": "Group", "id": "NCT00806442-comparison-group-1", "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: [System]-to-FEvIR Converter"}}], "identifier": [{"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-comparison-group-1", "assigner": {"display": "Computable Publishing LLC"}}], "title": "NCT00806442 Comparison Group: 2: Placebo Comparator", "status": "active", "description": "Placebo comparator: 9 g/day corn oil", "useContext": [{"code": {"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure", "code": "ArmGroupType", "display": "Arm Group Type"}, "valueCodeableConcept": {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ArmGroupType", "code": "PLACEBO_COMPARATOR", "display": "Placebo Comparator"}]}}], "membership": "conceptual", "characteristic": [{"code": {"text": "Exposed to"}, "valueReference": {"reference": "#NCT00806442-dietary-supplement------corn-oil", "type": "EvidenceVariable", "display": "Dietary Supplement: Corn Oil"}, "exclude": false}]}, {"resourceType": "PractitionerRole", "id": "NCT00806442-ResponsibleParty-0", "practitioner": {"display": "Elliot Israel, MD"}, "organization": {"display": "Brigham and Women's Hospital"}, "code": [{"text": "Principal Investigator"}]}, {"resourceType": "Location", "id": "NCT00806442-Location-0", "name": "Asthma Research Center, Brigham and Women's Hospital", "address": {"city": "Boston", "state": "Massachusetts", "postalCode": "02115", "country": "United States"}, "position": {"longitude": -71.05977, "latitude": 42.35843}}], "extension": [{"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "registration-submission", "display": "Registration submission"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"start": "2008-12-09"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "results-submission", "display": "Results submission"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"start": "2014-07-16"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "registration-submission-qc", "display": "Registration submission Quality Check"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"start": "2008-12-09"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "results-submission-qc", "display": "Results submission Quality Check"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"start": "2017-06-06"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "record-verification", "display": "Record Verification"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"end": "2017-06"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "update-submission", "display": "Update submission"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"end": "2017-06-06"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "registration-posting", "display": "Registration posting"}]}}, {"url": "actual", "valueBoolean": false}, {"url": "period", "valuePeriod": {"start": "2008-12-10"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "results-posting", "display": "Results posting"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"start": "2017-07-03"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "primary-outcome-data-collection", "display": "Primary outcome data collection"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"end": "2012-04"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"extension": [{"url": "activity", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/research-study-registration-activity", "code": "update-posting", "display": "Update posting"}]}}, {"url": "actual", "valueBoolean": true}, {"url": "period", "valuePeriod": {"end": "2017-07-03"}}], "url": "http://hl7.org/fhir/StructureDefinition/researchStudy-studyRegistration"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter"}}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "urn:ietf:rfc:3986", "value": "https://fevir.net/FOI/346639", "assigner": {"display": "Computable Publishing LLC"}}, {"use": "official", "system": "https://clinicaltrials.gov", "value": "NCT00806442"}, {"value": "2008p001696", "assigner": {"display": "Brigham and Women's Hospital"}}, {"value": "P50AT002782", "type": {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-SecondaryIdType", "code": "NIH", "display": "U.S. NIH Grant/Contract"}]}}], "name": "NCT00806442_FHIR_Transform", "title": "Treatment of Bronchial Asthma With Borage and Echium Seed Oils", "label": [{"type": {"coding": [{"system": "http://hl7.org/fhir/title-type", "code": "official", "display": "Official title"}]}, "value": "Treatment of Bronchial Asthma With Borage and Echium Seed Oils"}], "relatedArtifact": [{"type": "transforms", "document": {"url": "https://clinicaltrials.gov/api/v2/studies/NCT00806442?format=json"}}, {"type": "transformed-with", "display": "Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter", "document": {"url": "https://fevir.net/resources/Project/29885"}}, {"type": "supported-with", "classifier": [{"text": "Secondary Study ID Link for P50AT002782"}], "document": {"url": "https://reporter.nih.gov/quickSearch/P50AT002782"}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "BACKGROUND", "display": "background"}]}], "citation": "James MJ, Ursin VM, Cleland LG. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr. 2003 May;77(5):1140-5. doi: 10.1093/ajcn/77.5.1140.", "resourceReference": {"reference": "Citation/346632", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "12716664"}}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "BACKGROUND", "display": "background"}]}], "citation": "Chilton-Lopez, Surette ME, Swan DD, Fonteh AN, Johnson MM, Chilton FH. Metabolism of gammalinolenic acid in human neutrophils. J Immunol. 1996 Apr 15;156(8):2941-7.", "resourceReference": {"reference": "Citation/346633", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "8609415"}}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "BACKGROUND", "display": "background"}]}], "citation": "Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997 Aug;127(8):1435-44. doi: 10.1093/jn/127.8.1435.", "resourceReference": {"reference": "Citation/346634", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "9237935"}}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "BACKGROUND", "display": "background"}]}], "citation": "Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000 Aug;130(8):1925-31. doi: 10.1093/jn/130.8.1925.", "resourceReference": {"reference": "Citation/346635", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "10917903"}}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "BACKGROUND", "display": "background"}]}], "citation": "Surette ME, Koumenis IL, Edens MB, Tramposch KM, Chilton FH. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Clin Ther. 2003 Mar;25(3):948-71. doi: 10.1016/s0149-2918(03)80116-9.", "resourceReference": {"reference": "Citation/346636", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "12852710"}}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "BACKGROUND", "display": "background"}]}], "citation": "Surette ME, Koumenis IL, Edens MB, Tramposch KM, Clayton B, Bowton D, Chilton FH. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther. 2003 Mar;25(3):972-9. doi: 10.1016/s0149-2918(03)80117-0.", "resourceReference": {"reference": "Citation/346637", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "12852711"}}}, {"type": "cites", "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-ReferenceType", "code": "DERIVED", "display": "derived"}]}], "citation": "Kazani S, Arm JP, Boyce J, Chhay H, Dutile S, Wechsler ME, Govindarajulu U, Ivester P, Ainsworth HC, Sergeant S, Chilton FH, Israel E. LTC4 synthase polymorphism modifies efficacy of botanical seed oil combination in asthma. Springerplus. 2014 Nov 6;3:661. doi: 10.1186/2193-1801-3-661. eCollection 2014.", "resourceReference": {"reference": "Citation/346638", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "25485197"}}}, {"type": "supported-with", "classifier": [{"text": "Asthma Research Center, Brigham and Women's Hospital"}], "document": {"url": "http://asthmabwh.org"}}], "status": "active", "primaryPurposeType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-prim-purp-type", "code": "treatment", "display": "Treatment"}]}, "phase": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-phase", "code": "phase-1-phase-2", "display": "Phase 1/Phase 2"}]}, "studyDesign": [{"text": "Design Masking: Triple"}, {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-WhoMasked", "code": "PARTICIPANT", "display": "Participant"}, {"system": "https://fevir.net/sevco", "code": "SEVCO:01060", "display": "Blinding of study participants"}]}, {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-WhoMasked", "code": "INVESTIGATOR", "display": "Investigator"}, {"system": "https://fevir.net/sevco", "code": "SEVCO:01063", "display": "Blinding of data analysts"}]}, {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-WhoMasked", "code": "OUTCOMES_ASSESSOR", "display": "Outcomes Assessor"}, {"system": "https://fevir.net/sevco", "code": "SEVCO:01062", "display": "Blinding of outcome assessors"}]}, {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-DesignAllocation", "code": "RANDOMIZED", "display": "Randomized"}, {"system": "https://fevir.net/sevco", "code": "SEVCO:01003", "display": "randomized assignment"}]}, {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-InterventionalAssignment", "code": "CROSSOVER", "display": "Crossover Assignment"}, {"system": "https://fevir.net/sevco", "code": "SEVCO:01012", "display": "Crossover cohort design"}]}, {"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-StudyType", "code": "INTERVENTIONAL", "display": "Interventional"}, {"system": "https://fevir.net/sevco", "code": "SEVCO:01001", "display": "interventional research"}]}], "condition": [{"text": "Bronchial Asthma"}], "keyword": [{"text": "Asthma"}, {"text": "Fatty acids"}, {"text": "Leukotrienes"}, {"text": "Diet"}], "descriptionSummary": "The aim of this trial is to determine the efficacy of a combination of two botanicals oils, borage seed oil and echium seed oil, as a potential treatment for bronchial asthma.", "description": "Leukotrienes are important in the pathogenesis of inflammation, and leukotriene modifying drugs are now an established treatment for bronchial asthma and rhinitis. Drugs that inhibit the biosynthesis of leukotrienes are likely to be more effective than the currently available drugs that antagonize a single leukotriene receptor. Dietary supplementation with gamma linolenic acid (GLA) in borage seed oil provides effective inhibition of leukotriene generation but also increases circulating free arachidonic acid (AA), which has pro-inflammatory potential. The n-3 fatty acid, eicosapentaenoic acid (EPA), prevented the conversion of GLA to AA. However, EPA is extracted from fish oil, is not well-tolerated due to its taste, and at higher doses appeared to blunt the inhibition of leukotriene biosynthesis by GLA. Stearidonic acid (SDA) is a precursor of EPA that is extracted from Echium plantagineum; it is converted to EPA in humans and it does not have the organoleptic properties of EPA.\n\nWe recently completed a dose-ranging study in which we determined the dose of SDA that is sufficient to inhibit the rise in circulating levels of arachidonic acid while maintaining effective inhibition of leukotriene generation.\n\nThe goal of the present study is to test the efficacy of dietary supplementation with GLA and SDA (provided in borage seed oil and echium seed oil) in treating bronchial asthma.", "site": [{"reference": "#NCT00806442-Location-0", "type": "Location"}], "classifier": [{"text": "Has Results: True"}, {"text": "Oversight Classifier: oversightHasDmc False"}, {"text": "AgreementPISponsorEmployee: True"}, {"text": "AgreementRestrictiveAgreement: False"}], "associatedParty": [{"name": "Brigham and Women's Hospital", "role": {"coding": [{"system": "http://hl7.org/fhir/research-study-party-role", "code": "sponsor", "display": "Sponsor"}]}, "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-AgencyClass", "code": "OTHER", "display": "OTHER"}]}]}, {"name": "Elliot Israel, MD", "role": {"coding": [{"system": "http://hl7.org/fhir/research-study-party-role", "code": "primary-investigator", "display": "Primary Investigator"}]}, "party": {"reference": "#NCT00806442-ResponsibleParty-0", "type": "PractitionerRole"}}, {"name": "Brigham and Women's Hospital", "role": {"coding": [{"system": "http://hl7.org/fhir/research-study-party-role", "code": "lead-sponsor", "display": "lead-sponsor"}]}, "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-AgencyClass", "code": "OTHER", "display": "OTHER"}]}]}, {"name": "Wake Forest University Health Sciences", "role": {"coding": [{"system": "http://hl7.org/fhir/research-study-party-role", "code": "collaborator", "display": "Collaborator"}]}, "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-AgencyClass", "code": "OTHER", "display": "OTHER"}]}]}, {"name": "National Center for Complementary and Integrative Health (NCCIH)", "role": {"coding": [{"system": "http://hl7.org/fhir/research-study-party-role", "code": "collaborator", "display": "Collaborator"}]}, "classifier": [{"coding": [{"system": "https://clinicaltrials.gov/data-about-studies/study-data-structure#enum-AgencyClass", "code": "NIH", "display": "NIH"}]}]}, {"name": "Elliot Israel, MD", "role": {"coding": [{"system": "http://hl7.org/fhir/research-study-party-role", "code": "primary-investigator", "display": "Primary Investigator"}]}, "party": {"display": "Brigham and Women's Hospital"}}], "progressStatus": [{"state": {"coding": [{"system": "http://hl7.org/fhir/research-study-status", "code": "completed", "display": "Completed"}]}}, {"state": {"coding": [{"system": "http://hl7.org/fhir/research-study-status", "code": "overall-study", "display": "Overall study"}]}, "actual": false, "period": {"start": "2008-12"}}, {"state": {"coding": [{"system": "http://hl7.org/fhir/research-study-status", "code": "overall-study", "display": "Overall study"}]}, "actual": true, "period": {"end": "2012-08"}}], "recruitment": {"actualNumber": 43, "eligibility": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442 Eligibility Criteria", "assigner": {"display": "Computable Publishing LLC"}}}}, "comparisonGroup": [{"extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-comparison-group-eligibility", "valueReference": {"reference": "#NCT00806442-comparison-group-0", "type": "Group", "display": "1: Borage Seed Oil and Echium Seed Oil: Borage/Echium plant seed oils: 2 g/day of borage seed oil and 7 g/day of echium seed oil to provide 1.6 g/day of GLA and 0.9 g/day of SDA."}}]}, {"extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-comparison-group-eligibility", "valueReference": {"reference": "#NCT00806442-comparison-group-1", "type": "Group", "display": "2: Placebo Comparator: Placebo comparator: 9 g/day corn oil"}}]}], "objective": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "primary", "display": "Primary"}]}, "extension": [{"extension": [{"url": "name", "valueString": "Forced Expiratory Volume in 1 Second (FEV1)"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "primary", "display": "Primary"}]}}, {"url": "description", "valueMarkdown": "Forced expiratory volume in 1 second (FEV1) in plant seed oil vs. placebo"}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-primaryOutcome-0", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}, "extension": [{"extension": [{"url": "name", "valueString": "Positive FEV1 Percent Predicted Change Among C Allele Carriers and A Homozygotes"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}}, {"url": "description", "valueMarkdown": "Number of participants with positive change in FEV1 % predicted (\\>0%) among C allele carriers and A homozygotes in each arm"}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-secondaryOutcome-0", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}, {"extension": [{"url": "name", "valueString": "Peak Flow Rate (PEFR)"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}}, {"url": "description", "valueMarkdown": "Morning Peak Flow Rate in plant seed oil vs. placebo"}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-secondaryOutcome-1", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}, {"extension": [{"url": "name", "valueString": "Frequency of Rescue Use of Short Acting Beta-2 Agonists"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}}, {"url": "description", "valueMarkdown": "Average number of puffs of albuterol daily in plant seed oil vs. placebo"}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-secondaryOutcome-2", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}, {"extension": [{"url": "name", "valueString": "Day-time Symptoms of Bronchial Asthma"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}}, {"url": "description", "valueMarkdown": "Day-time symptom scores in plant seed oil vs. placebo. 0 = Absent: No symptoms\n\n1. = Mild: Symptom did not interfere with normal daily activity or sleep\n2. = Moderate: Symptom was sufficient to interfere with normal daily activity or sleep\n3. = Severe: Symptom was so severe as to prevent normal daily activity or sleep\n\nThese numbers were used for 1. Shortness of breath 2. Chest tightness 3. Wheezing 4. Cough 5. Phlegm/Mucus.\n\nThe total score is the sum of the 5 item scores, for a range of 0-15. A higher score represents more severe symptoms. Each participant's score is the average of varying numbers of diary cards. The treatment phase visits at 6 weeks consisted of 3 weeks of diary cards with a +/- 5 day window. The baseline visits had 2 weeks of diary cards with a +/- 5 day window. The treatment phase measures are adjusted for the baseline measures."}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-secondaryOutcome-3", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}, {"extension": [{"url": "name", "valueString": "Night-time Wakenings"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}}, {"url": "description", "valueMarkdown": "Average number of night-time wakenings in plant seed oil vs. placebo"}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-secondaryOutcome-4", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}, {"extension": [{"url": "name", "valueString": "Urinary Leukotriene Levels"}, {"url": "type", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type", "code": "secondary", "display": "Secondary"}]}}, {"url": "description", "valueMarkdown": "Urinary leukotriene levels in plant seed oil vs. placebo"}, {"url": "endpoint", "valueReference": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442-secondaryOutcome-5", "assigner": {"display": "Computable Publishing LLC"}}}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-outcome-measure"}]}], "result": [{"type": "EvidenceReport", "display": "Results Section for NCT00806442", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT00806442 Results Report", "assigner": {"display": "Computable Publishing LLC"}}}], "meta": {"versionId": "1", "lastUpdated": "2025-03-07T13:32:01.373Z"}, "url": "https://fevir.net/resources/ResearchStudy/346639", "id": "346639"}